Is Novozymes AS stock a buy?
What Is The Conclusion?
Right now our advanced algorithms say:
Do the analyst corps agree?
Interesting Questions and Easy Answers!
Yes, Novozymes AS pays dividends. Last time was Tuesday 3rd of September 2024 where the investors holding the stock on Friday 30th of August 2024 were paid $0.297 per share. Over the last 13 times between 2014 and 2024, Novozymes AS has paid $7.96979 with an average of $0.61 per share.
Sorry, we do not have any analyst data for this ticker
We cannot find data for Novozymes AS 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was $46.63, you would have made a profit of $10.52 per share or 22.56%
No, the average daily trading liquidity for Novozymes AS is $620 thousand. Trading in stocks with this little trading liquidity is very dangerous, and you can get into a situation where it will be hard to trade your stocks. In addition, these types of stocks usually have very high volatility.
Novozymes AS has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a normal cash flow to debt ratio of 0.45, the company's ability to pay off the debt is normal. Novozymes AS has a good net profit margin of 9.29% and should have high tolerances against inflation.
We have calculated the inflation risk for Novozymes AS to be low [0.4 of 1]
US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.